Table 2.
Clinical Characteristics
| All Patients (N=5906) | Oral (n=1701) | Injectable (n=3748) | Infusion (n=457) | |
|---|---|---|---|---|
| Comorbidity n (%) | ||||
| Bladder dysfunction | 1071 (18.1) | 367 (21.6) | 605 (16.1) | 99 (21.7) |
| Bowel dysfunction | 629 (10.7) | 185 (10.9) | 377 (10.1) | 67 (14.7) |
| Depression | 1305 (22.1) | 385 (22.6) | 787 (21.0) | 133 (29.1) |
| Diabetes | 630 (10.7) | 183 (10.8) | 404 (10.8) | 43 (9.4) |
| Dizziness and vertigo | 1128 (19.1) | 291 (17.1) | 731 (19.5) | 106 (23.2) |
| Fatigue | 2025 (34.3) | 545 (32.0) | 1296 (34.6) | 184 (40.3) |
| Gait and mobility difficulties | 1315 (22.3) | 413 (24.3) | 756 (20.2) | 146 (32.0) |
| Gastrointestinal disease | 819 (13.9) | 220 (12.9) | 531 (14.2) | 68 (14.9) |
| Hyperlipidemia | 1618 (27.4) | 479 (28.2) | 1042 (27.8) | 97 (21.2) |
| Hypertension | 1735 (29.4) | 491 (28.9) | 1137 (30.3) | 107 (23.4) |
| Neuropathic pain | 1314 (22.3) | 344 (20.2) | 872 (23.3) | 98 (21.4) |
| Other chronic pain | 442 (7.5) | 140 (8.2) | 267 (7.1) | 35 (7.7) |
| Pruritus | 75 (1.3) | 31 (1.8) | 37 (1.0) | 7 (1.5) |
| Pseudobulbar affect | 7 (0.1) | 4 (0.2) | 1 (0.0) | 2 (0.4) |
| Sexual problems | 111 (1.9) | 29 (1.7) | 73 (2.0) | 9 (2.0) |
| Spasticity | 329 (5.6) | 107 (6.3) | 199 (5.3) | 23 (5.0) |
| Tremors | 83 (1.4) | 32 (1.9) | 42 (1.1) | 9 (2.0) |
| Urinary tract infection | 942 (16.0) | 294 (17.3) | 561 (15.0) | 87 (19.0) |